Feature|Podcasts|March 25, 2026

Beyond the Hospital Walls: Expanding Access to Complex Cancer Therapies

Fact checked by: Sabrina Serani

Discover how CAR-T, bispecifics and gene therapy reshape cancer care—and what clinics need for safe, reimbursable outpatient delivery closer to home.

In this episode of the Treating Together podcast, host Dr Pallav Mehta, medical oncologist at MD Anderson Cancer Center at Cooper, assistant professor of medicine at Cooper Medical School, and medical director of Reimagine Care, sits down with Jorge Garcia, PharmD, founder of Patagonia Healthcare, for an in-depth conversation about the rapidly evolving landscape of advanced cancer therapies, from CAR-T cells and bispecific antibodies to gene therapies.


Together, they explore what makes these treatments fundamentally different from traditional chemotherapy and immunotherapy, and why the systems built to deliver them must evolve just as quickly. The discussion covers the operational, financial, and clinical challenges facing health systems looking to bring bispecific therapies into community and outpatient settings — including reimbursement models, toxicity monitoring, caregiver education, and the critical role of oncology pharmacists. Dr Mehta and Dr Garcia also look ahead to the growing promise of technology, AI, and virtual care in enabling safer patient monitoring outside of hospital walls, and share their vision for a future where more patients can receive these transformative treatments closer to home.

Whether you're a clinician, administrator, pharmacist, or healthcare innovator, this conversation offers a grounded and forward-looking perspective on what it will take to make cutting-edge cancer care accessible to all patients—not just those near major academic centers.


Latest CME